Baxter(US:BAX) Financial Modeling Prep·2026-02-13 03:14Core Viewpoint - Baxter International Inc. is facing challenges in financial performance despite reporting strong sales growth, leading to a negative market reaction and a cautious outlook for 2026 [2][5][6] Financial Performance - Baxter reported fourth-quarter sales of $2.974 billion, an 8% increase year over year, exceeding the consensus estimate of $2.824 billion [3][6] - The adjusted earnings per share (EPS) for the quarter was 44 cents, which fell short of management's guidance and Wall Street expectations due to an unfavorable product mix [2][6] - The adjusted gross margin contracted by 900 basis points to 35.5%, and operating income decreased by 16% year over year [4] Market Reaction - Following the earnings report, Baxter's stock price declined by 12.5%, reflecting investor concerns over the company's performance [4] - The stock is currently priced at $18.71, representing a decrease of 15.99% over the past year [5] Future Outlook - Baxter's guidance for 2026 indicates flat sales growth or a slight increase of just 1%, with EPS projected between $1.85 and $2.05, which is below consensus estimates [5][6] - Ongoing disruptions at a crucial manufacturing unit are contributing to the negative outlook and market reaction [5]